Free US stock valuation models and price target projections from professional analysts covering Wall Street expectations and analyst consensus. We help you understand fair value estimates and potential upside or downside scenarios for any stock you are considering. Our platform provides multiple valuation methods, comparable company analysis, and discounted cash flow models. Make smarter valuation decisions with our comprehensive tools and expert projections based on Wall Street research.
As of 2026-04-07, Lexicon Pharmaceuticals Inc. (LXRX) trades at a current price of $1.6, posting a modest intraday gain of 0.63% during the regular session. This analysis evaluates key technical levels, prevailing market context, and potential short-term price scenarios for the clinical-stage pharmaceutical firm, with no recent earnings data available for the company at the time of writing. While LXRX has traded within a narrow short-term range in recent weeks, investors are monitoring both tech
Are insiders buying or selling Lexicon Pharmaceuticals (LXRX) Stock | Price at $1.60, Up 0.63% - Gamma Alerts
LXRX - Stock Analysis
3616 Comments
1719 Likes
1
Nyjee
Elite Member
2 hours ago
Short-term pullbacks may present buying opportunities.
👍 90
Reply
2
Krishen
Registered User
5 hours ago
Ah, if only I had caught this before. 😔
👍 112
Reply
3
Shelane
Engaged Reader
1 day ago
If only I had read this earlier. 😔
👍 189
Reply
4
Kristyanne
New Visitor
1 day ago
Missed it completely… 😩
👍 162
Reply
5
Mashea
Consistent User
2 days ago
Wish I had seen this earlier… 😩
👍 191
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.